Reprogramming Cellular Identity for Regenerative Medicine

Although development leads unidirectionally toward more restricted cell fates, recent work in cellular reprogramming has proven that one cellular identity can strikingly convert into another, promising countless applications in biomedical research and paving the way for modeling diseases with patient-derived stem cells. To date, there has been little discussion of which disease models are likely to be most informative. Here, we review evidence demonstrating that, because environmental influences and epigenetic signatures are largely erased during reprogramming, patient-specific models of diseases with strong genetic bases and high penetrance are likely to prove most informative in the near term. We also discuss the implications of the new reprogramming paradigm in biomedicine and outline how reprogramming of cell identities is enhancing our understanding of cell differentiation and prospects for cellular therapies and in vivo regeneration.

[1]  D. Pei,et al.  Induced Pluripotent Stem Cells Can Be Used to Model the Genomic Imprinting Disorder Prader-Willi Syndrome* , 2010, The Journal of Biological Chemistry.

[2]  R. Jaenisch,et al.  Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats , 2010, Proceedings of the National Academy of Sciences.

[3]  T. Golub,et al.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9 , 2006, Nature.

[4]  R. Waterland,et al.  Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. , 2004, Nutrition.

[5]  Brian E. McIntosh,et al.  Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy , 2011, Proceedings of the National Academy of Sciences.

[6]  C. Siu,et al.  Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin A/C , 2011, Aging.

[7]  Ji Young Kim,et al.  Induced pluripotent stem cell models from X‐linked adrenoleukodystrophy patients , 2011, Annals of neurology.

[8]  Patrick A. Lewis,et al.  Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus , 2011, Nature communications.

[9]  Hidenori Akutsu,et al.  DNA Methylation Dynamics in Human Induced Pluripotent Stem Cells over Time , 2011, Human Cell.

[10]  Gustavo Turecki,et al.  Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse , 2009, Nature Neuroscience.

[11]  G. Daley,et al.  Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. , 2010, Cell stem cell.

[12]  Nicholas Eriksson,et al.  Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's Disease , 2011, PLoS genetics.

[13]  Andrew P. Feinberg,et al.  Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells , 2011, Nature Biotechnology.

[14]  R. Malekzadeh,et al.  Generation of Liver Disease-Specific Induced Pluripotent Stem Cells Along with Efficient Differentiation to Functional Hepatocyte-Like Cells , 2010, Stem Cell Reviews and Reports.

[15]  Ying Sun,et al.  Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies , 2011, Cell.

[16]  R. Jaenisch,et al.  Nuclear Cloning and Epigenetic Reprogramming of the Genome , 2001, Science.

[17]  Lior Gepstein,et al.  Modelling the long QT syndrome with induced pluripotent stem cells , 2011, Nature.

[18]  Martin J. Aryee,et al.  Epigenetic memory in induced pluripotent stem cells , 2010, Nature.

[19]  P. Mali,et al.  Efficient Generation of Functional Dopaminergic Neurons from Human Induced Pluripotent Stem Cells Under Defined Conditions , 2010, Stem cells.

[20]  S. Haggarty,et al.  Epigenetic Characterization of the FMR1 Gene and Aberrant Neurodevelopment in Human Induced Pluripotent Stem Cell Models of Fragile X Syndrome , 2011, PloS one.

[21]  Carl T. Bergstrom,et al.  A population-epigenetic model to infer site-specific methylation rates from double-stranded DNA methylation patterns. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Blake Byers,et al.  LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. , 2011, Cell stem cell.

[23]  A. Lindgren,et al.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.

[24]  Jason Hipp,et al.  Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. , 2004, Cloning and stem cells.

[25]  W. G. Hill,et al.  Heritability in the genomics era — concepts and misconceptions , 2008, Nature Reviews Genetics.

[26]  George Q. Daley,et al.  Reprogramming of human somatic cells to pluripotency with defined factors , 2008, Nature.

[27]  James A. Thomson,et al.  Induced pluripotent stem cells from a spinal muscular atrophy patient , 2009, Nature.

[28]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[29]  A. Caspi,et al.  A longitudinal study of epigenetic variation in twins , 2010, Epigenetics.

[30]  Tim D. Spector,et al.  A twin approach to unraveling epigenetics , 2011, Trends in genetics : TIG.

[31]  V. Vedantham,et al.  Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors , 2010, Cell.

[32]  G. Daley,et al.  Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients , 2009, Nature.

[33]  Gang Wang,et al.  Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy , 2011, Nature Cell Biology.

[34]  Hynek Wichterle,et al.  Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons , 2008, Science.

[35]  N. Chao Faculty Opinions recommendation of In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. , 2008 .

[36]  Fumitaka Osakada,et al.  Modeling Retinal Degeneration Using Patient-Specific Induced Pluripotent Stem Cells , 2011, PloS one.

[37]  T. Graf,et al.  Making Eosinophils Through Subtle Shifts in Transcription Factor Expression , 2002, The Journal of experimental medicine.

[38]  R. Lafyatis,et al.  Generation of Transgene‐Free Lung Disease‐Specific Human Induced Pluripotent Stem Cells Using a Single Excisable Lentiviral Stem Cell Cassette , 2010, Stem cells.

[39]  A. Kaneda,et al.  Fidelity of the methylation pattern and its variation in the genome. , 2003, Genome research.

[40]  Douglas A. Melton,et al.  In vivo reprogramming of adult pancreatic exocrine cells to β-cells , 2008, Nature.

[41]  D. Fisher,et al.  Melanocyte biology and skin pigmentation , 2007, Nature.

[42]  Lee E. Edsall,et al.  Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. , 2010, Cell stem cell.

[43]  C. Dang,et al.  Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. , 2009, Blood.

[44]  J. Wagner,et al.  Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa. , 2011, The Journal of investigative dermatology.

[45]  Angelique M. Nelson,et al.  Engineering of human pluripotent stem cells by AAV-mediated gene targeting. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[46]  George Q. Daley,et al.  Disease-Specific Induced Pluripotent Stem Cells , 2008, Cell.

[47]  Beau R. Webber,et al.  Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome). , 2011, Blood.

[48]  R. Stewart,et al.  Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells , 2011, Nature.

[49]  A. Feinberg,et al.  Intra-individual change over time in DNA methylation with familial clustering. , 2008, JAMA.

[50]  B. Strulovici,et al.  Induced pluripotent stem cells — opportunities for disease modelling and drug discovery , 2011, Nature Reviews Drug Discovery.

[51]  Daniel T. Montoro,et al.  Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells , 2010, PLoS currents.

[52]  Martin J. Aryee,et al.  Personalized Epigenomic Signatures That Are Stable Over Time and Covary with Body Mass Index , 2010, Science Translational Medicine.

[53]  Stormy J. Chamberlain,et al.  Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader–Willi syndromes , 2010, Proceedings of the National Academy of Sciences.

[54]  Qi Zhou,et al.  iPS cells produce viable mice through tetraploid complementation , 2009, Nature.

[55]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[56]  M. Skinner,et al.  Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease. , 2006, Endocrinology.

[57]  Fred H. Gage,et al.  A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells , 2010, Cell.

[58]  P. Mali,et al.  Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease. , 2011, Blood.

[59]  Martin J Aryee,et al.  Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts , 2009, Nature Genetics.

[60]  G. Neri,et al.  Faculty Opinions recommendation of Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. , 2009 .

[61]  Ludovic Vallier,et al.  Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. , 2010, The Journal of clinical investigation.

[62]  R. Murray,et al.  Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. , 1999, Archives of general psychiatry.

[63]  E. Kroon,et al.  Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo , 2008, Nature Biotechnology.

[64]  Huang,et al.  Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin , 2011 .

[65]  K. Hochedlinger,et al.  Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells , 2010, Nature Biotechnology.

[66]  D. Krainc,et al.  Mitochondrial Parkin Recruitment Is Impaired in Neurons Derived from Mutant PINK1 Induced Pluripotent Stem Cells , 2011, The Journal of Neuroscience.

[67]  A. Viale,et al.  Modeling Pathogenesis and Treatment of Familial Dysautonomia using Patient Specific iPSCs , 2009, Nature.

[68]  Katriina Aalto-Setälä,et al.  Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture , 2011, Disease Models & Mechanisms.

[69]  J. C. Belmonte,et al.  Diseases in a dish: modeling human genetic disorders using induced pluripotent cells , 2011, Nature Medicine.

[70]  Karl-Ludwig Laugwitz,et al.  Patient-specific induced pluripotent stem-cell models for long-QT syndrome. , 2010, New England Journal of Medicine.

[71]  Richard P Davis,et al.  Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation. , 2005, Blood.

[72]  E. Behr,et al.  Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. , 2008, European heart journal.

[73]  A. Muotri,et al.  Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients , 2011, Human molecular genetics.

[74]  Robin Goland,et al.  Generation of pluripotent stem cells from patients with type 1 diabetes , 2009, Proceedings of the National Academy of Sciences.

[75]  H. Payami,et al.  The heritability of risk and age at onset of Parkinson's disease after accounting for known genetic risk factors , 2010, Journal of Human Genetics.

[76]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[77]  T. Ichisaka,et al.  GENERATION OF GERMLINECOMPETENT INDUCED PLURIPOTENT STEM CELLS , 2007 .

[78]  H. Weintraub,et al.  Expression of a single transfected cDNA converts fibroblasts to myoblasts , 1987, Cell.

[79]  Rudolf Jaenisch,et al.  Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors , 2009, Cell.

[80]  M. Busslinger,et al.  Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors , 2007, Nature.

[81]  A. Schambach,et al.  Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin. , 2011, Human molecular genetics.

[82]  A. Feinberg,et al.  Stochastic epigenetic variation as a driving force of development, evolutionary adaptation, and disease , 2010, Proceedings of the National Academy of Sciences.

[83]  S. Blanchard,et al.  Modeling neuronal defects associated with a lysosomal disorder using patient-derived induced pluripotent stem cells. , 2011, Human molecular genetics.

[84]  H. Okano,et al.  Modeling familial Alzheimer's disease with induced pluripotent stem cells. , 2011, Human molecular genetics.

[85]  H. Wichterle,et al.  Directed Differentiation of Embryonic Stem Cells into Motor Neurons , 2002, Cell.

[86]  Linzhao Cheng,et al.  Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting. , 2011, Blood.

[87]  Hyeon Joo Lee,et al.  Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. , 2003, The American journal of pathology.

[88]  Arturas Petronis,et al.  Epigenetics and twins: three variations on the theme. , 2006, Trends in genetics : TIG.

[89]  T. Ichisaka,et al.  Generation of germline-competent induced pluripotent stem cells , 2007, Nature.

[90]  M. Oshimura,et al.  Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[91]  G. Nardone,et al.  Helicobacter pylori and Epigenetic Mechanisms Underlying Gastric Carcinogenesis , 2007, Digestive Diseases.

[92]  Lei Yang,et al.  Patient-specific induced pluripotent stem cell derived models of LEOPARD syndrome , 2010, Nature.

[93]  Douglas C. Miller,et al.  A large kindred with autosomal dominant Parkinson's disease , 1990, Annals of neurology.

[94]  G. Daley,et al.  Induced pluripotent stem cells for modelling human diseases , 2011, Philosophical Transactions of the Royal Society B: Biological Sciences.

[95]  Ya-min Wu,et al.  Directed differentiation of embryonic stem cells into motor neurons by gene , 2004 .

[96]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[97]  Fred H. Gage,et al.  Modelling schizophrenia using human induced pluripotent stem cells , 2011, Nature.

[98]  Jinqiu Zhang,et al.  A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. , 2011, Cell stem cell.

[99]  Thomas Vierbuchen,et al.  Direct conversion of fibroblasts to functional neurons by defined factors , 2010, Nature.

[100]  P. Delvenne,et al.  Epithelial metaplasia: adult stem cell reprogramming and (pre)neoplastic transformation mediated by inflammation? , 2009, Trends in molecular medicine.

[101]  P. Mali,et al.  Improved Efficiency and Pace of Generating Induced Pluripotent Stem Cells from Human Adult and Fetal Fibroblasts , 2008, Stem cells.

[102]  Wei Jiang,et al.  Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells , 2009, Cell Research.